Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cr 605
1. 55837-29-1
2. Tiropramide [inn]
3. Cr-605
4. R7s0904cn2
5. Tiropramide (inn)
6. Benzenepropanamide, Alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)-n,n-dipropyl-, (+-)-
7. Tiropramida [spanish]
8. Tiropramida
9. Tiropramidum
10. Tiropramidum [inn-latin]
11. Tiropramida [inn-spanish]
12. N-(3-(4-(2-(diethylamino)ethoxy)phenyl)-1-(dipropylamino)-1-oxopropan-2-yl)benzamide
13. N-[3-[4-[2-(diethylamino)ethoxy]phenyl]-1-(dipropylamino)-1-oxopropan-2-yl]benzamide
14. (+/-)-tiropramide
15. Brn 4162600
16. Maioral
17. Tirospan
18. Unii-r7s0904cn2
19. O-(diethylaminoethyl)-n-benzoyl-dl-tyrosyl-di-n-propylamide
20. Tiropramide [mi]
21. Dl-alpha-benzamido-para-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
22. (+-)-alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)-n,n-dipropylbenzenepropanamide
23. Schembl25693
24. Tiropramide [who-dd]
25. Chembl2104688
26. Dtxsid70866514
27. Chebi:135758
28. Akos015909639
29. Dl-alpha-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
30. Db13091
31. D07087
32. Q7809264
33. (+/-)-.alpha.-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
34. Dl-.alpha.-benzamido-p-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide
35. N-(2-{4-[2-(diethylamino)ethoxy]phenyl}-1-(dipropylcarbamoyl)ethyl)benzenecarboximidic Acid
| Molecular Weight | 467.6 g/mol |
|---|---|
| Molecular Formula | C28H41N3O3 |
| XLogP3 | 5.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 15 |
| Exact Mass | 467.31479218 g/mol |
| Monoisotopic Mass | 467.31479218 g/mol |
| Topological Polar Surface Area | 61.9 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 561 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AC - Synthetic antispasmodics, amides with tertiary amines
A03AC05 - Tiropramide
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
A Tiropramide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiropramide, including repackagers and relabelers. The FDA regulates Tiropramide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiropramide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tiropramide supplier is an individual or a company that provides Tiropramide active pharmaceutical ingredient (API) or Tiropramide finished formulations upon request. The Tiropramide suppliers may include Tiropramide API manufacturers, exporters, distributors and traders.
Tiropramide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiropramide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiropramide GMP manufacturer or Tiropramide GMP API supplier for your needs.
A Tiropramide CoA (Certificate of Analysis) is a formal document that attests to Tiropramide's compliance with Tiropramide specifications and serves as a tool for batch-level quality control.
Tiropramide CoA mostly includes findings from lab analyses of a specific batch. For each Tiropramide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiropramide may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiropramide EP), Tiropramide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiropramide USP).
LOOKING FOR A SUPPLIER?
